Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT00001337 |
| Title | Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult | child |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Holy Cross Hospital, Fort Lauderdale | Fort Lauderdale | Florida | 33308 | United States | Details | |
| University of Maryland, Baltimore | Baltimore | Maryland | 21201-1595 | United States | Details | |
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | United States | Details | |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | United States | Details | |
| St. Luke's Roosevelt Hospital | New York | New York | 10025 | United States | Details |